438 related articles for article (PubMed ID: 28823831)
1. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
2. GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.
Sakaki H; Okada M; Kuramoto K; Takeda H; Watarai H; Suzuki S; Seino S; Seino M; Ohta T; Nagase S; Kurachi H; Kitanaka C
Anticancer Res; 2015 Dec; 35(12):6607-14. PubMed ID: 26637876
[TBL] [Abstract][Full Text] [Related]
3. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
4. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
[TBL] [Abstract][Full Text] [Related]
5. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
Rath BH; Waung I; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
[TBL] [Abstract][Full Text] [Related]
8. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
[TBL] [Abstract][Full Text] [Related]
9. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
Ma X; Zhang Y; Kang Y; Li L; Zheng W
Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
[TBL] [Abstract][Full Text] [Related]
11. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
12. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y
Int J Oncol; 2009 May; 34(5):1381-6. PubMed ID: 19360350
[TBL] [Abstract][Full Text] [Related]
13. Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane.
Bayat Mokhtari R; Baluch N; Morgatskaya E; Kumar S; Sparaneo A; Muscarella LA; Zhao S; Cheng HL; Das B; Yeger H
BMC Cancer; 2019 Aug; 19(1):864. PubMed ID: 31470802
[TBL] [Abstract][Full Text] [Related]
14. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
15. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
16. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
17. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
18. GSKJ4 Protects Mice Against Early Sepsis via Reducing Proinflammatory Factors and Up-Regulating MiR-146a.
Pan Y; Wang J; Xue Y; Zhao J; Li D; Zhang S; Li K; Hou Y; Fan H
Front Immunol; 2018; 9():2272. PubMed ID: 30337925
[TBL] [Abstract][Full Text] [Related]
19. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]